磁共振弹性成像对肝纤维化分级诊断价值的Meta分析

doi:10.13481/j.1671-587x.20170424

摘要/Abstract

摘要： 目的：采用Meta分析方法探讨磁共振弹性成像（MRE）对肝纤维化分级的诊断效能及临床应用价值，为临床对肝纤维化的治疗提供依据。方法：搜索2017年2月2日前国内外公开发表的MRE诊断肝纤维化分级的中文和英文文献。纳入数据库包括PubMed、EMBase、Web of Science、Cochrane Library、中国知网、中国生物医学文献数据库、维普数据库和万方数据库，并辅以手工检索，按照预先纳入及排除标准进行筛选，提取资料，采据QUADAS-2工具进行文献质量评价，采用Stata软件分别对F0 vs F1-F4组、F0-F1 vs F2-F4组、F0-F2 vs F3-F4组和F0-F3 vs F4组MRE对肝纤维化分期诊断的敏感度（SEN）、特异度（SPE）、诊断比值比（DOR）、阳性似然比（+LR）和阴性似然比（-LR）进行合并计算及异质性检验，绘制分层综合受试者工作特征曲线（HSROC），计算曲线下面积（AUROC）。结果：共检索出1 332篇文献，最后纳入22篇，其中英文21篇，中文1篇。Meta分析，SEN_合并、SPE_合并、+LR_合并、-LR_合并、DOR_合并和AUROC，F0 vs F1-F4组分别为88.8%（85.0%~91.7%）、95.9%（91.5%~98.0%）、21.435（10.215~44.979）、0.117（0.086~0.159）、183.187（72.533~462.650）和0.96（0.94~0.98），F0-F1 vs F2-F4组分别为93.3%（89.2%~35.9%）、94.1%（90.2%~96.5%）、15.839（9.344~26.848）、0.072（0.044~0.117）、221.224（100.980~484.648）和0.98（0.96~0.99），F0-F2 vs F3-F4组分别为92.9%（88.9%~95.5%）、94.6%（91.2%~96.8%）、17.348（10.496~28.671）、0.075（0.048~0.119）、230.434（111.482~476.317）和0.98（0.96~0.99），F0-F3 vs F4组分别为97.7%（93.0%~99.3%）、93.2%（90.3%~95.2%）、14.337（9.910~20.742）、0.025（0.008~0.075）、580.405（144.871~2 325.307）和0.98（0.96~0.99）。结论：MRE作为一种新型和无创的影像检查手段，对不同分期肝纤维化均具有较高诊断价值，可为临床肝纤维化的精准治疗提供可靠参考。

关键词: 肝硬化, Meta分析, 磁共振弹性成像, 肝纤维化, 诊断效能

Abstract: Objective: To investigate the efficacy and the clinical value of magnetic resonance elastography(MRE) in diagnosis of hepatic fibrosiswith Meta-analysis, and to provide basis for clinical treatment of hepatic fibrosis.Methods: The studies published before February 2, 2017 about MRE and staging of hepatic fibrosis in Chinese or English were retrived in the databases including PubMed, EMBase, Web of Science, Cochrane Library,CNKI, CBMDisc,VIP, Wanfang data, and supplemented by manual retrieval for relevant literatures. The inclusion and exclusion criterions were used to select and extract the literatures.The literatures qualitie were valuated based on QUADAS-2 tool.The sensitivity(SEN), specificity (SPE), diagnostic odds ratio (DOR), positive likelihood ratio (+LR), negative likelihood ratio (-LR) on the groups of F0 vs F1-F4,F0-F1 vs F2-F4,F0-F2 vs F3-F4, F0-F3 vs F4 and heterogeneity were combined and tested with Stata software respectively.HSROC and AUROC were also implemented.Results: A total of 1 332 studies were searched, and 22 were included. 21 of them were in English and 1 in Chinese. The results of Meta analysis showed that the SENp, SPEp, +LRp, -LRp, DOR and AUROC in F0 vs F1-F4 group were 88.8%(85.0-91.7),95.9%(91.5-98.0),21.435(10.215-44.979),0.117(0.086-0.159),183.187(72.533-462.650) and 0.96(0.94-0.98),respectively;the SENp, SPEp, +LRp, -LRp, DOR and AUROC in F0-F1 vs F2-F4 group were 93.3%(89.2%-35.9%), 94.1%(90.2%-96.5%),15.839(9.344-26.848),0.072(0.044-0.117),221.224(100.980-484.648) and 0.98(0.96-0.99),respectively; the SENp, SPEp, +LRp, -LRp, DOR and AUROC in F0-F2 vs F3-F4 group were 92.9%(88.9%-95.5%),94.6%(91.2%-96.8%),17.348(10.496-28.671),0.075(0.048-0.119),230.434(111.482-476.317)0.98(0.96-0.99), respectively;the SENp, SPEp, +LRp, -LRp, DOR and AUROC in F0-F3 vs F4 group were 97.7%(93.0%-99.3%),93.2%(90.3%-95.2%),14.337(9.910-20.742),0.025(0.008-0.075),580.405(144.871-2325.307) and 0.98(0.96-0.99),respectively.Conclusion: MRE,as a new and noninvasive imaging method, has high diagnostic value in all stages of hepatic fibrosis, which can provide a reliable reference for clinical precise treatment of hepatic fibrosis.

Key words: magnetic resonance elastography, diagnostic efficiency, hepatic fibrosis, hepatocirrhosis, Meta-analysis

中图分类号:

R445.2

牛猛, 邓大勇, 李云鹏飞, 刘硕, 丁军. 磁共振弹性成像对肝纤维化分级诊断价值的Meta分析[J]. 吉林大学学报(医学版), 2017, 43(04): 787-793.

NIU Meng, DENG Dayong, LI Yunpengfei, LIU Shuo, DING Jun. Values of MRE in diagnosis of stages of hepatic fibrosis:A Meta-analysis[J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 787-793.

参考文献

[1] Pellicoro A,Ramachandran P,Iredale JP,et al. Liver fibrosis and repair:immune regulation of wound healing in a solid organ[J].Nature Revi Immunol,2014,14(3):181-194.
[2] Friedman SL,Bansal MB. Reversal of hepatic fibrosis-fact or fantasy?[J]. Hepatology,2006,43(2 Suppl 1):S82-S88.
[3] Gonzalez HC,Jafri SM,Gordon SC. Role of liver biopsy in the era of direct-acting antivirals[J].Curr Gastroenterol Rep,2013,15(2):307.
[4] Yin M,Talwalkar JA,Glaser KJ,et al.Assessment of hepatic fibrosis with magnetic resonance elastography[J].Clin Gastroenterol Hepatol, 2007,5(10):1207-1213.
[5] Huwart L,Sempoux C,Salameh N,et al.Liver ifbrosis:Noninvasive assessment with MR elastography versus aspartate aminotransferase toplatelet ratio index[J]. Radiology,2007, 245(2):458-466.
[6] Huwart L,Sempoux C,Vicaut E,et al.Magnetic resonance elastography for the noninvasive staging of liver fibrosis[J]. Gastroenterology,2008,135(1):32-40.
[7] Asbach P,Klatt D,Schlosser B,et al.Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography[J]. Radiology,2010,257(1):80-86.
[8] Lee VS,Miller FH,Omary RA,et al.Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis c in liver transplant recipients[J]. Transplantation, 2011, 92(5):581-586.
[9] Wang Y,Ganger DR,Levitsky J,et al.Assessment of chronic hepatitis and fib-rosis:comparison of MR elastography and diffusion-weighted imaging[J].AJR Am J Roentgenol,2011,196(3):553-561.
[10] Kim BH,Lee JM,Lee YJ,et al.MR elastography for noninvasive assessment of hepatic fibrosis:expeirence from a tertiay center in Asia[J].Magn Reson Imaging,2011,34(5):1110-1116.
[11] Kampues C, Klatt D,Bova R,et al.Visco-elasticity-based magnetic resonance elastography for the assessment of liver fibrosis in hepatitis C patients after liver transplation[J].Rofo, 2012, 184(11):1013-1019.
[12] Rustogi R,Horowitz J,Harmath C,et al.Accuracy of MR elastography and anatomic MR imaging features in the diagnosisof severe hepatic fibrosis and cirhosis[J].Magn Reson Imaging,2012, 35(6):1356-1364.
[13] Ichikawa S,Motosugi U,Ichikawa T,et al.Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C[J].Magn Reson Med Sci,2012,11(4):291-297.
[14] Choi YR,Lee JM,Yoon JH,et al.Compraison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evlauation of heptaic ifbrosis[J].Invest Radiol,2013,48(8):607-613.
[15] Lee JE,Lee JM,Lee KB,et al.Noninvasive assessment of hepatic fibrosis in patients with chronic hepatitis B viral infection using magnetic resonance elastography[J].Korean J Radiol,2014,15(2):210-217.
[16] Yoon JH,Lee JM,Woo HS,et al. Staging of hepatic fibrosis:comparison of magnetic resonance elastography and shear wave elastography in the same individuals[J].Korean J Radiol,2013,14(2):202-212.
[17] Venkatesh SK,Wang G,Lim SG,et al.Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B[J].Eur Radiol,2014,24(1):70-78.
[18] Batheja M,Vargas H,Silva AM,et al.Magnetic resonance elastography (MRE) in assessing hepatic fibrosis:performance in a cohort of patients with histological data[J].Abdom Imaging,2015,40(4):760-765.
[19] Shi Y,Guo Q,Xia F,et al.MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection:Does histologic necroinflammation influence the measurement of hepatic stiffness?[J].Radiology,2014,273(1):88-98.
[20] Ichikawa S,Motosugi U,Morisaka H,et al.Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis[J].Magan Reson Imaging, 2015, 33(1):26-30.
[21] Ichikawa S,Motosugi U,Moriska H,et al.MRI-based staging of hepatic fibrosis:Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic Resonance elastography[J].Magn Reson Imaging,2015,36(6):315-320.
[22] Wu WP,Chou CT,Chen RC,et al.Non-Invasive evaluation of hepatic fibrosis:The diagnostic performance of magnetic resonance elastography in patients with viral hepatitis B or C[J].PLoS One, 2015,10(10):425-439.
[23] Shi Y,Xia F,Li QJ,et al. Magnetic resonance elastography for the evaluation of Liver fibrosis in chronic hepatitis B and C by using Both gradient-recalled echo and spin-echo echo planar imaging:A prospective study[J].Am J Gastroenterol,2016, 111(6):823-833.
[24] 刘莹,石喻,于兵,等.磁共振弹性成像与DWI诊断肝纤维化分期[J].中国医学影技,2016,32(9):1386-1390.
[25] Toguchi M, Tsurusaki M, Yada N, et al. Magnetic resonance elastography in the assessment of hepatic fibrosis:a study comparing transient elastography and histological data in the samepatients[J]. Abdominal Radiol, 2017,32:2-9.
[26] 王威,温锋,赵相轩,等.磁共振弹性成像评价肝纤维化分期的Meta分析[J].中国临床医学影像杂志,2015,26(5):329-334.
[27] Wang QB,Zhu H,Liu HL,et al. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis:A Meta-analysis[J].Hepatology,2012,56(1):239-247.
[28] 刘茜玮,谢晟,王武,等.磁共振弹性成像[J].中国医疗器械信息,2011,10(10):11-18.
[29] 朱传龙,王坤,高人焘.肝纤维无创性诊断技术的临床应用[J].临床肝胆病杂志,2015,31(3):332-336.
[30] 武琼,徐光华.肝纤维化非创伤性诊断的新近认识[J].临床肝胆病杂志,2015,31(2):295-299.